Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-027063

Chief Development Officer sold 12,000 shares at an average $12.31 ($147,729)

  • Chief Development Officer acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-06-06 Option exercise 10b5-1 +11,900 $4.30 $51,170 102,347 D
Michaelson Jennifer Chief Development Officer 2023-06-06 Sale 10b5-1 −11,900 $12.31 $146,489 90,447 D
Michaelson Jennifer Chief Development Officer 2023-06-07 Option exercise 10b5-1 +100 $4.30 $430 90,547 D
Michaelson Jennifer Chief Development Officer 2023-06-07 Sale 10b5-1 −100 $12.40 $1,240 90,447 D
Derivatives
Michaelson Jennifer Chief Development Officer 2023-06-06 Option exercise · Stock Option (Right to Buy) 10b5-1 −11,900 188,693 D
Michaelson Jennifer Chief Development Officer 2023-06-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −100 188,593 D
Open-market sales · 12,000 sh · avg $12.31 · $147,729
Loading xslF345X04/ownership.xml…